A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis
NCT01077869 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2011-05-26
Summary
In this study, the feasibility of optical imaging and FDG-PET in the evaluation of radiation-induced mucositis will be evaluated.
Conditions
- Squamous Cell Carcinoma of the Oral Cavity
- Oropharynx Metastases
- Lymph Metastases
Interventions
- PROCEDURE
-
endoscopic examination
on a weekly basis during 7 weeks
- PROCEDURE
-
FDG-PET
once pre-radiotherapy and once 2 weeks after initiation of radiotherapy
Sponsors & Collaborators
-
University Hospital, Ghent
lead OTHER
Principal Investigators
-
wilfried De Neve, MD, PhD · University Hospital, Ghent
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2011-05-31
- Completion
- 2011-05-31
Countries
- Belgium
Study Locations
More Related Trials
-
PET/CT and Sentinel Node in Oral Cancer
NCT01136265 ·Status: UNKNOWN
-
Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer
NCT03181035 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
NCT05994768 ·Status: COMPLETED
-
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
NCT05030597 ·Status: RECRUITING
-
Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
NCT02469922 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager
NCT03561324 ·Status: WITHDRAWN ·Phase: NA
-
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
NCT00721799 ·Status: COMPLETED ·Phase: PHASE2
-
PET With [18F]HX4 in Head and Neck Cancer
NCT01347281 ·Status: COMPLETED ·Phase: NA
-
Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer
NCT03053960 ·Status: TERMINATED
-
Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4
NCT04017819 ·Status: SUSPENDED ·Phase: PHASE1
-
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
NCT07285564 ·Status: RECRUITING ·Phase: NA
-
Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
NCT00180245 ·Status: COMPLETED
-
PET-CT Based Radiotherapy in Esophageal Cancer Patients
NCT01156831 ·Status: COMPLETED
-
Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors
NCT04552847 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging
NCT03303469 ·Status: TERMINATED ·Phase: PHASE2
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity.
NCT03947892 ·Status: UNKNOWN
-
Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors
NCT00163176 ·Status: COMPLETED
-
Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma
NCT06947759 ·Status: NOT_YET_RECRUITING
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma
NCT04417985 ·Status: COMPLETED ·Phase: NA
-
PET Imaging of Intracranial Cancers With 18F-FSPG
NCT02370563 ·Status: TERMINATED ·Phase: PHASE1
-
F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
NCT02149173 ·Status: TERMINATED ·Phase: NA